Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;34(11):918-21.
doi: 10.3760/cma.j.issn.0253-2727.2013.11.002.

[Detection of intron 22 inversion of factor VIII gene in severe hemophilia A patients]

[Article in Chinese]
Affiliations

[Detection of intron 22 inversion of factor VIII gene in severe hemophilia A patients]

[Article in Chinese]
Zhi-ping Guo et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Nov.

Abstract

Objective: To investigate the incidence of intron 22 inversion (INV22) of factor VIII (FVIII) gene in severe hemophilia A (HA) patients, clarify its pathological mechanism, and identify INV22 carrier in the female family members.

Methods: One-stage method was used to assay the FVIII activity (FVIII:C)in 126 severe HA patients with a median age of 14 years old (range: 4 months-63 years). INV22 was analyzed by long-distance polymerase chain reaction (LD-PCR) and pulsed field gel electrophoresis (PFGE), and pedigree were conducted in 3 involved HA families.

Results: Of all the 126 severe HA, 52 (41.3%) cases had the INV22. Four females including 3 mothers and 1 sister of probands were diagnosed as INV22 carriers among 11 suspected carrier mosaicisms from 3 INV22 positive HA families. In 8 females from one family without HA history, the patient's mother was a INV22 carrier, but her maternal grandmother, 2 maternal aunts, 2 female siblings and 1 elder female cousin were negative.

Conclusion: LD-PCR and PFGE could be used to diagnose severe HA patients with INV22 and identify the carriers.

PubMed Disclaimer

Publication types